In the instance of constitutive activation of a downstream signaling module such as Akt, the inhibition of the higher-level receptor will be futile, and given the rate of occurrence of this mutation across all cancer types, it is likely that this played a role (Figure 2). This evidence concerns the gene AKT1 and cancer.